-transparent.png){kind=logo}
Solid organ transplant recipients undergoing immunosuppressive therapy are considered to be at high risk for serious infectious complications. Recently in the United States, a pandemic of H1N1 flu infection has been reported with serious complications. We describe H1N1 infection in a living kidney donor and the 42-year-old kidney transplant recipient exposed to this kidney donor and undergoing intense immunosuppressive therapy. Postexposure prophylaxis with oseltamivir was effective to prevent H1N1 influenza A virus in a donor and a recipient.
Related Publications
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
January 2004,
ACP journal club,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
February 1994,
Transplantation proceedings,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
June 2004,
Current infectious disease reports,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
January 2022,
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
August 2012,
Pediatric transplantation,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
April 1990,
Vaccine,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
January 2011,
The Journal of the Association of Physicians of India,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
October 2016,
The Journal of hospital infection,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
February 2002,
Transplantation proceedings,
K Marfo, and
J Chapochnick-Friedmann, and
E Akalin, and
A Lu
September 2009,
MMWR. Morbidity and mortality weekly report,
